ARK Genomic Revolution ETF vs Innodata Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.59, while Innodata Inc trades at $61.97 (market cap $2.05B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Innodata Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | INOD | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $121.50 |
52-Week Low | $24.02 | $34.45 |
Market Cap | — | $2.05B |
Enterprise Value | — | $1.80B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
INOD trades at $61.40, down 1.33% today, but maintains a bullish technical signal with oscillators supporting upside momentum. The company reported strong Q2 2026 results, beating EPS estimates with $0.41 versus $0.21 expected, driven by 58% revenue growth and AI-driven demand expansion. Valuation ratios remain elevated with a P/E of 48.62, reflecting high growth expectations.
Outlook is positive given consistent earnings beats and AI sector tailwinds, but risks include premium valuation sensitivity and customer concentration. Analyst consensus is bullish with a $130 price target, suggesting significant upside potential if execution continues.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →